Shopping Cart 0
Cart Subtotal
AED 0

Merrimack Pharmaceuticals Inc (MACK) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company's marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (marketed chemotherapy drug) in a liposomal formulation used in the treatment of pancreatic metastatic adenocarcinoma. Its pipeline portfolio includes investigational candidates targeted at the treatment of advanced non-small cell lung cancer (NSCLC), solid tumors, metastatic breast cancer, and heregulin positive breast cancer. The company sells its products through a network of distributors in the US. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc (MACK)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Merrimack Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Partnerships 10

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 10

Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 11

Equity Offering 12

Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 12

Merrimack Pharmaceuticals Inc-Key Competitors 13

Merrimack Pharmaceuticals Inc-Key Employees 14

Merrimack Pharmaceuticals Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 16

Financial Announcements 16

Aug 07, 2018: Merrimack reports second quarter 2018 financial results 16

May 08, 2018: Merrimack Reports First Quarter 2018 Financial Results 18

Mar 12, 2018: Merrimack Reports 2017 Financial Results 19

Aug 09, 2017: Merrimack Reports Second Quarter 2017 Financial Results 21

May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results 22

Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results 24

Corporate Communications 26

May 23, 2018: Merrimack is recognized in Harvard Business School/Kraft Precision Trials Challenge 26

Nov 30, 2017: Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors 27

Aug 14, 2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer 28

Jun 08, 2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources 29

May 25, 2017: Merrimack Announces Management Change 30

Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Merrimack Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 10

Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 11

Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 12

Merrimack Pharmaceuticals Inc, Key Competitors 13

Merrimack Pharmaceuticals Inc, Key Employees 14

Merrimack Pharmaceuticals Inc, Subsidiaries 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Merrimack Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company's marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (marketed chemotherapy drug) in a liposomal formulation used in the treatment of pancreatic metastatic adenocarcinoma. Its pipeline portfolio includes investigational candidates targeted at the treatment of advanced non-small cell lung cancer (NSCLC), solid tumors, metastatic breast cancer, and heregulin positive breast cancer. The company sells its products through a network of distributors in the US. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc (MACK)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Merrimack Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Partnerships 10

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 10

Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 11

Equity Offering 12

Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 12

Merrimack Pharmaceuticals Inc-Key Competitors 13

Merrimack Pharmaceuticals Inc-Key Employees 14

Merrimack Pharmaceuticals Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 16

Financial Announcements 16

Aug 07, 2018: Merrimack reports second quarter 2018 financial results 16

May 08, 2018: Merrimack Reports First Quarter 2018 Financial Results 18

Mar 12, 2018: Merrimack Reports 2017 Financial Results 19

Aug 09, 2017: Merrimack Reports Second Quarter 2017 Financial Results 21

May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results 22

Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results 24

Corporate Communications 26

May 23, 2018: Merrimack is recognized in Harvard Business School/Kraft Precision Trials Challenge 26

Nov 30, 2017: Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors 27

Aug 14, 2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer 28

Jun 08, 2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources 29

May 25, 2017: Merrimack Announces Management Change 30

Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Merrimack Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merrimack Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merrimack Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Merrimack Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 10

Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 11

Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 12

Merrimack Pharmaceuticals Inc, Key Competitors 13

Merrimack Pharmaceuticals Inc, Key Employees 14

Merrimack Pharmaceuticals Inc, Subsidiaries 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Merrimack Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.